Table 2. The association of the 13 miRNAs and the miRNA signature risk score with clinical features in PC patients (presented as P value).

ID	Gender (female VS. male)	Age (< 65 VS. ≥ 65)	Grade (G1 + G2 VS. G3 + G4)	Tumor size (< 35 mm VS. ≥ 35 mm)	Stage (I vs. II VS. III + IV)	Smoking (smoker VS. non-smoker)	Drinking (drinker VS. non-drinker)	Diabetes (yes VS. no)	Location (head VS. body VS. tail)
miR-103-2	0.528	0.308	0.864	0.137	0.785	0.587	0.006	0.28	0.152
miR-125a	0.077	0.143	0.17	0.657	0.108	0.448	0.884	0.83	0.292
miR-126	0.116	0.379	0.845	0.434	0.626	0.313	0.034	0.969	0.728
miR-328	0.062	0.626	0.701	0.228	0.309	0.502	0.698	0.833	0.117
miR-340	0.812	0.84	0.925	0.106	0.202	0.156	0.023	0.799	0.445
miR-361	0.016	0.03	0.392	0.976	0.409	0.01	0.07	0.311	0.803
miR-374b	0.565	0.57	0.928	0.616	0.869	0.652	0.022	0.149	0.389
miR-454	0.596	0.957	0.635	0.614	0.092	0.412	0.07	0.358	0.661
miR-627	0.743	0.842	0.12	0.505	0.356	0.934	0.005	0.743	0.128
miR-664	0.507	0.895	0.74	0.085	0.526	0.81	0.085	0.487	0.339
miR-193b	0.91	0.684	0.074	0.321	0.009	0.478	0.583	0.44	0.822
miR-21	0.438	0.511	0.56	0.017	0.045	0.41	0.783	0.814	0.807
miR-584	0.618	0.267	0.886	0.129	0.059	0.899	0.821	0.803	0.577
Risk score	0.573	0.264	0.81	0.932	0.23	0.247	0.112	0.72	0.145